| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/03/2012 | US8088820 Substituted tetracycline compounds for the treatment of malaria |
| 01/03/2012 | US8088819 Derivatives of substituted 3-phenyl-1-(phenylthienyl)propan-1-ones and of 3-phenyl-1-(phenylfuranyl) propan-1-ones, preparation and use |
| 01/03/2012 | US8088818 Catechol-based derivatives for treating or preventing diabetics |
| 01/03/2012 | US8088817 Pyrrole derivative having, as substituents, ureido group, aminocarbonly group and bicyclic group which may have substituent |
| 01/03/2012 | US8088816 3-3-di-substituted-oxindoles as inhibitors of translation initiation |
| 01/03/2012 | US8088815 Spiroindolinone pyrrolidines |
| 01/03/2012 | US8088814 Methods and compositions for the treatment of psychiatric disorders |
| 01/03/2012 | US8088813 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
| 01/03/2012 | US8088812 Sigma receptor inhibitors |
| 01/03/2012 | US8088811 Heterocycle derivatives useful as selective androgen receptor modulators (SARMs) |
| 01/03/2012 | US8088810 Phenoxypyrazole composition and process for the solvent extraction of metals |
| 01/03/2012 | US8088809 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| 01/03/2012 | US8088808 Substituted N-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 01/03/2012 | US8088807 Microbicidal composition |
| 01/03/2012 | US8088806 Thiazole compounds and methods of use |
| 01/03/2012 | US8088805 Anticancer agents; antiproliferative agents |
| 01/03/2012 | US8088804 N-hydroxyamide derivatives possessing antibacterial activity |
| 01/03/2012 | US8088803 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 01/03/2012 | US8088802 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
| 01/03/2012 | US8088801 Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof |
| 01/03/2012 | US8088800 4-(5-aminomethyl)-indole-1-ylmethyl)-benzamide derivatives and related compounds as opioid receptor antagonists for the treatment of obesity |
| 01/03/2012 | US8088799 Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor |
| 01/03/2012 | US8088798 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity |
| 01/03/2012 | US8088796 Triamine derivative |
| 01/03/2012 | US8088795 Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and p53 |
| 01/03/2012 | US8088794 Substituted amide derivatives and methods of use |
| 01/03/2012 | US8088793 Certain chemical entities, compositions, and methods |
| 01/03/2012 | US8088792 Triazolopyridinone derivatives for use as stearoyl CoA desaturase inhibitors |
| 01/03/2012 | US8088790 Hydroxy and alkoxy substituted 1H-imidazoquinolines and methods |
| 01/03/2012 | US8088789 Administering hemiketal ring and seco-macrocyclic lactones; immunosuppressive, anti-proliferative, anti-fungal and anti-tumor |
| 01/03/2012 | US8088788 Substituted fused[1,2] imidazo[4,5-c] ring compounds and methods |
| 01/03/2012 | US8088787 Methods related to the treatment of neurodegenerative and inflammatory conditions |
| 01/03/2012 | US8088786 tablets comprising sustained release and time release drug multilayers interspersed with one or more intermediate layers, useful for affecting weight loss, suppressing appetite or treating obesity |
| 01/03/2012 | US8088785 Therapeutic compound and treatments |
| 01/03/2012 | US8088784 4-(3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer |
| 01/03/2012 | US8088783 MAPK/ERK kinase inhibitors |
| 01/03/2012 | US8088782 Crystalline 4-(3-chloro-2-fluoroanilino)-7 methoxy-6-{[1-(N-methylcarbamoylmethyl)piperidin-4-yl]oxy}quinazoline difumarate form A |
| 01/03/2012 | US8088781 Inhibitors of brutons tyrosine kinase |
| 01/03/2012 | US8088780 5,7-disubstituted thiazolo[4,5-D]pyrimidines for the selective inhibition of chemokine receptors |
| 01/03/2012 | US8088779 Pyrazolo [1,5-alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists |
| 01/03/2012 | US8088778 Benzisoxazole piperazine compounds and methods of use thereof |
| 01/03/2012 | US8088777 Urea derivative |
| 01/03/2012 | US8088776 Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 01/03/2012 | US8088775 Pharmaceutical composition for treating hair loss |
| 01/03/2012 | US8088774 Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death |
| 01/03/2012 | US8088773 Therapeutic compositions and methods |
| 01/03/2012 | US8088772 Sulfonamides and their use as a medicament |
| 01/03/2012 | US8088771 Cycloalkylidene and heterocycloalkylidene inhibitor compounds |
| 01/03/2012 | US8088770 Modulators of pharmacokinetic properties of therapeutics |
| 01/03/2012 | US8088769 e.g. 2-(3,4-Dichlorophenyl)ethanamidine hydrochloride; phosphodiesterases inhibitor; learning enhancement, cognition activator; improving perception, concentration, or memory |
| 01/03/2012 | US8088768 Protein kinase and phosphatase inhibitors |
| 01/03/2012 | US8088767 JAK-2 modulators and methods of use |
| 01/03/2012 | US8088766 Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors |
| 01/03/2012 | US8088765 Polysubstituted derivatives of 6-heteroarylimidazo[1,2-a]pyridines, and preparation and therapeutic use thereof |
| 01/03/2012 | US8088764 Compound useful for the treatment of degenerative and inflammatory diseases |
| 01/03/2012 | US8088763 e.g. N-[1-(2,6-dichloro-benzyl)-pyrrolidin-3-yl]-N'-[4-dimethylamino-4-(4-methyl-benzyl)-cyclohexyl]-succinamide; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases |
| 01/03/2012 | US8088762 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 01/03/2012 | US8088761 Enzyme inhibitors |
| 01/03/2012 | US8088760 Benzoxazole carboxamide inhibitors of poly(ADP-ribose)polymerase (PARP) |
| 01/03/2012 | US8088759 1,4-benzodiazepine-2,5-diones with therapeutic properties |
| 01/03/2012 | US8088758 17β-hydroxysteroid dehydrogenase type I inhibitors |
| 01/03/2012 | US8088757 Betulinol derivatives as anti-cancer agents |
| 01/03/2012 | US8088755 11a, 12-derivatives of tetracycline compounds |
| 01/03/2012 | US8088754 Anti-proliferative compounds, compositions, and methods of use thereof |
| 01/03/2012 | US8088753 Heparin conjugates and methods |
| 01/03/2012 | US8088752 Methods for metabolic modulation |
| 01/03/2012 | US8088747 Analogue compounds of archaebacterial membrane lipids and liposomal compounds integrating such compounds |
| 01/03/2012 | US8088746 Bis-modified bicyclic nucleic acid analogs |
| 01/03/2012 | US8088745 Methods for assaying alpha-L-iduronidase enzymatic activity |
| 01/03/2012 | US8088744 Cholestanol derivative for combined use |
| 01/03/2012 | US8088743 Sodium dependent glucose transporter (SGLT2); such as dapagliflozin, dapagliflozin-PGS, a C-glucoside or an O-glucoside |
| 01/03/2012 | US8088742 Polyol-glycoside compositions for the skin |
| 01/03/2012 | US8088737 Treating a cancer, in particular breast cancer, that overexpresses Her-2 by administering an ADAM inhibitor; novel variants of ADAM15 and ADAM15; synergistic effect between inhibition of Her-2 cleavage by an ADAM and certain cytostatic (e.g., Herceptin) and cytotoxic (e.g., Taxol) compounds |
| 01/03/2012 | US8088732 Compositions comprising physiologic concentrations of cytokines |
| 01/03/2012 | US8088605 Exopolysaccharides delivery system for active molecules |
| 01/03/2012 | US8088429 Package drink |
| 01/03/2012 | US8088419 Sulfur-containing proanthocyanidin oligomer composition and production method thereof |
| 01/03/2012 | US8088415 Core-and-shell dosage form or unit in which the core contains API and in which the shell substantially governs the release such as by controlling diffusion of API through the shell. The shell may comprise a release-blocking polymer, and particles |
| 01/03/2012 | US8088410 25-hydroxy Vitamin D3 compositions |
| 01/03/2012 | US8088407 Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
| 01/03/2012 | US8088405 Therapeutic compositions and methods |
| 01/03/2012 | US8088402 Bone growth compositions and methods |
| 01/03/2012 | US8088400 Disinfectant with quarternary ammonium polymer and copolymers |
| 01/03/2012 | US8088398 Pharmaceutical compositions comprising fesoterodine |
| 01/03/2012 | US8088395 Phytol derived immunoadjuvants and their use in vaccine formulations |
| 01/03/2012 | US8088388 Complexing; water in oil emulsion; immunostimulant |
| 01/03/2012 | US8088385 PFKB3 inhibitor for the treatment of a proliferative cancer |
| 01/03/2012 | US8088371 Deliver platelet rich plasma, sodium bicarbonate, calcium gluconate, choline chloride buffers, thrombin, collagen, epinephrine releasate, via catheter; coat suture, stent, screw, plate implants with plasma |
| 01/03/2012 | US8088368 Antiviral compounds |
| 01/03/2012 | US8088365 Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution |
| 01/03/2012 | US8088363 Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin |
| 01/03/2012 | US8088362 Salmeterol superfine formulation |
| 01/03/2012 | CA2713466C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 01/03/2012 | CA2690293C Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with rage |
| 01/03/2012 | CA2676910C Medicament for the treatment of endometriosis |
| 01/03/2012 | CA2671954C Methods for treating or preventing symptoms of hormonal variations |
| 01/03/2012 | CA2667566C Pyrazole analogs |
| 01/03/2012 | CA2662148C Phthalazine, aza- and diaza-phthalazine compounds and medicinal uses thereof |
| 01/03/2012 | CA2661197C Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy |
| 01/03/2012 | CA2655692C Alkyl-pyridazine derivatives as inhibitors of 11 beta hydroxysteroid dehydrogenase type 1(11b-hsd 1) |